Items Tagged ‘esophago-gastric cancer’

October 3, 2017

New Standard of Care for Treatment of Resectable Gastric Cancer


The superiority of docetaxel based triplet therapy over standard care in patients with resectable esophago-gastric cancer has been confirmed in late-breaking results from the FLOT4 trial presented at the ESMO 2017 Congress in Madrid.1 Survival in resectable esophago-gastric cancer is poor. Five-year overall survival is around 25% with surgery, and is increased to 36% by […]

View full entry

Tags: Esophageal Cancer, esophago-gastric cancer, Gastric Cancer, News